| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ... Nature, 2013 | 1985 | 2013 |
| Enhanced detection of circulating tumor DNA by fragment size analysis F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ... Science translational medicine 10 (466), eaat4921, 2018 | 938 | 2018 |
| Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ... Nature genetics 45 (9), 1055-1060, 2013 | 566 | 2013 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6, 8760, 2015 | 532 | 2015 |
| Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ... Nature communications 6 (1), 6605, 2015 | 410 | 2015 |
| Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma M Köbel, AM Piskorz, S Lee, S Lui, C LePage, F Marass, N Rosenfeld, ... The Journal of Pathology: Clinical Research 2 (4), 247-258, 2016 | 409 | 2016 |
| Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients F Mouliere, R Mair, D Chandrananda, F Marass, CG Smith, J Su, J Morris, ... EMBO molecular medicine 10 (12), e9323, 2018 | 173 | 2018 |
| ctDNA monitoring using patient-specific sequencing and integration of variant reads JCM Wan, K Heider, D Gale, S Murphy, E Fisher, F Mouliere, ... Science translational medicine 12 (548), eaaz8084, 2020 | 169 | 2020 |
| Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma L Gossage, M Murtaza, AF Slatter, CP Lichtenstein, A Warren, B Haynes, ... Genes, chromosomes and cancer 53 (1), 38-51, 2014 | 160 | 2014 |
| Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer KM Patel, KE Van Der Vos, CG Smith, F Mouliere, D Tsui, J Morris, ... Scientific Reports 7 (1), 5554, 2017 | 114 | 2017 |
| Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients B Risberg, DWY Tsui, H Biggs, ARVM de Almagro, SJ Dawson, ... The Journal of Molecular Diagnostics 20 (6), 883-892, 2018 | 99 | 2018 |
| Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. R Mair, F Mouliere, CG Smith, D Chandrananda, D Gale, F Marass, ... Cancer Research, canres. 0074.2018, 2018 | 92 | 2018 |
| Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ... EMBO molecular medicine 10 (6), e7945, 2018 | 69 | 2018 |
| A phylogenetic latent feature model for clonal deconvolution F Marass, F Mouliere, K Yuan, N Rosenfeld, F Markowetz The Annals of Applied Statistics 10 (4), 2377-2404, 2016 | 59 | 2016 |
| A 44K microarray dataset of the changing transcriptome in developing Atlantic salmon (Salmo salar L.) SG Jantzen, DS Sanderson, KR von Schalburg, M Yasuike, F Marass, ... BMC research notes 4, 1-7, 2011 | 54 | 2011 |
| Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The … A Flory, KM Kruglyak, JA Tynan, LM McLennan, JM Rafalko, PC Fiaux, ... PLoS One 17 (4), e0266623, 2022 | 47 | 2022 |
| Fragment size analysis may distinguish clonal hematopoiesis from tumor-derived mutations in cell-free DNA F Marass, D Stephens, R Ptashkin, A Zehir, MF Berger, DB Solit, ... Clinical chemistry 66 (4), 616-618, 2020 | 47 | 2020 |
| Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience P Kothari, F Marass, JL Yang, CM Stewart, D Stephens, J Patel, M Hasan, ... Cancer medicine 9 (17), 6093-6101, 2020 | 44 | 2020 |
| BnpC: Bayesian non-parametric clustering of single-cell mutation profiles N Borgsmüller, J Bonet, F Marass, A Gonzalez-Perez, N Lopez-Bigas, ... Bioinformatics 36 (19), 4854-4859, 2020 | 20 | 2020 |
| Multiparametric circulating tumor cell analysis to select targeted therapies for breast cancer patients A Franken, B Behrens, F Reinhardt, L Yang, M Rivandi, F Marass, ... Cancers 13 (23), 6004, 2021 | 17 | 2021 |
Nitzan RosenfeldCancer Research UK Cambridge Institute and University of Cambridgeכתובת אימייל מאומתת בדומיין cruk.cam.ac.uk